Biodistribution of fetal thyroid hormone (RT3) was studied in nude mice with Ewing's sarcoma xenografts. At 30 min and 1, 2, 4, 8, and 12 hr after injection, blood, tumor and normal organs were measured to determine the amount of radioactivity per gram of tissue. The amount of radioactivity in the blood of tumor-bearing mice decreased sharply from 7.64% of injected dose per gram of tissue (% ID/g) at 30 min after inoculation to 0.45% ID/g at 12 hr. The % of injected dose per gram for 1251-labeled RT3 in the tumor reached 1.92 at 1 hr after injection and decreased to 0.22 at 12 hr. The radiolocalization indices for tumor to other organs at 12 hr ranged from 1.35 to 4.43. This study suggests increased localization of RT3 in the Ewing's sarcoma as compared to other tissues in the nude mouse.
Ewing's sarcoma ; nude mouse ; fetal thyroid hormone ; biodistribution study Fetal thyroid hormone or 3, 3', 5' triiodothyronine (RT3) is a metabolically inactive thyroid hormone after birth that exists in high concentration in the fetus (Nicod et al. 1976 ; Shulkin and Utiger 1984) . RT3 was also found in high concentration in some patients with end stage malignancy (Adami et al. 1978; Dessaint et al. 1978; Persson et al. 1985) . In a virus induced erythroleukemia cell model, RT3 was found to stimulate the growth of the erythroleukemia cell in culture (Gauwerky et al. 1981 ). Ewing's sarcoma is one of the most lethal of the bone tumors in spite of vigorous combined treatment of irradiation, systemic chemotherapy and surgical ablation. The growth of Ewing's sarcoma cells in culture has been shown to be stimulated by RT3 (Dutkowsky et al. 1989 (Dutkowsky et al. , 1991 . This implies the Received March 27, 1992; revision accepted for publication June 12, 1992 . The abbreviations used are : RT3, fetal thyroid hormone, 3, 3', 5' triiodothyronine %ID/g, % of injected dose per gram of tissue; RI, radiolocalization index=%ID/g in th tumor divided by %ID/g in the tissue. 239 e presence of a receptor to fetal thyroid hormone within these cells which may lead to potential advances in new cancer therapy (Dutkowsky et al. 1989 (Dutkowsky et al. , 1991 . This study of the biodistribution of labled RT3 in nude mice xenografted with Ewing's sarcoma was undertaken in order to determine if the sarcoma has RT3 specificity in vivo. RT3 labeled with 125I was obtained from Dupont (specific activity : 1.22 mCi/ug, radiochemical purity : > 99%, molecular weight : 649, N. Billerica, MA, USA). The 125I-labeled RT 3 (1251-RT3) was diluted with phosphate buffered saline (PBS, 0.85% sodium chloride in 0.15 M phosphate, pH 7.2, Sigma, St. Louis, MO, USA) for this in vivo study. A cloned Ewing's sarcoma cell line (ES 1) was obtained from the solid tumor culture laboratory of St. Jude Children's Research Hospital. The Ewing's sarcoma was grown in a standard tissue culture media RPMI 1640 (Gibco, Tulsa, OK, USA), containing 5% heatinactivated fetal calf serum (Sigma), 2 mM L-glutamine (Sigma), and 50 mg/liter of Gentamicine (Elkins-Sinn, Cherry Hill, NJ, USA). The cell line was tested for the presence of mycoplasma and was negative. The cells were subcultured weekly. The sarcoma cells were removed from culture flasks at confluence with trypsin, washed and concentrated in growth medium. Four week old female athymic mice (nu/nu) were obtained from Charles River Laboratories (Wilmington, MA, USA). After one week acclimation the mice were given subcutaneous injections in the right hind flank with approximately 4 X 106 Ewing's sarcoma cells. A total number of 18 athymic mice bearing tumors 0.3 to 1.5 cm in diameter approximately 3 weeks after inoculation were given intraperitoneal injections of 0.67 ,u Ci of 1251-RT 3 (1 x 106 cpm). The mice (3 per group) were anesthetised with ketamine (67 mg/kg, Aveco Co., Inc., Fort Dodge, IA, USA) and xylazine (13 mg/kg, The Butler Co., Columbus, OH, USA) and sacrificed at 30 min, l hr, 2 hr, 4 hr, 8 hr, and 12 hr by exsanguination. The tumor and selected normal tissues were removed and weighed, and radioactivity was measured with a gamma counter (Micromedic, Micromedic, Horsham, PA, USA). The counts per minute per milligram (cpm/mg) were calculated. The methods for evaluating the biodistributioin of 1251-RT3 were derived from the techniques used to study the localization of monoclonal antibodies in nude mice xenografted with tumor cells (Colcher et al. 1983 (Colcher et al. , 1984 (Colcher et al. , 1988 Brown et al. 1987) .
The percentage of the injected dose per gram of tissue (%ID/g) for blood, the tumor and the selected normal tissues were determined (Table 1 ) and radiolocalization indices (RIs) were calculated (%ID/g in the tumor divided by the %ID/g in the tissue) ( Table 2 ). TABLE 1. Percent injected 1251-RT3 dose per gram 1251-RT 3 was injected into athymic mice xenografted with Ewing's sarcoma. The mice (3 per group) were sacrificed at the indicated times and the %ID/ g for the tumor and selected normal organs were calculated.
As shown in Table 1 , the amount of radioactivity in the blood of tumor-bearing mice decreased sharply from 7.64 %ID/g at 30 min postinoculation to 0.45%ID/g at 12 hr. The 125I -RT3 demonstrated an extremely rapid clearance from the plasma , with most of the RT3 out of the plasma pool by 12 hr, which is probably due to its small molecular weight of 649. The %ID/g in the tumor reached a peak of 1.92 at 1 hr after injection and gradually dropped to 0.22 at 12 hr. The 125I-RT3 levels found in the selected normal organs, except the kidney and muscle, also reached their highest %ID/g at 1 hr and dropped to 0.05 to 0.16 at 12 hr. One possible explanation for the low %ID/g (0.05-2.52) of 125I-RT3 in the tissues may be due to intraperitoneal injection of 125I-RT3. It is possible to think that decrease of radioactivity in blood and organs is likely due to dehalogenation.
As shown in Table 2 , RIs of the organs ranged from 0.37 to 4.43. RIs of the organs except muscle were less than 1.00 at 30 min. All organ RIs except the liver and kidney exceeded 1.00 at 1 hr and thereafter. RIs of the liver and kidney were still less than or equal to 1.00 at 2 hr. Organ RIs gradually increased to 1.35 to 4.43 at 12 hr. RIs were greater than 3 for spleen, heart, and muscle at 12 hr. The large RIs of the organs show more radioactivity present in the Ewing's sarcoma than in the other tissues tested. The %ID/ g in the tumor tended to be higher than those in the other organs, and in general RI increased with time. To check statistical difference the Student's t-test was applied. The %ID/g in the tumor was significantly higher than those of liver (p <0.05), spleen (p <0.05), lung (p <0.05) and heart (p <0.01) at 4 hr. These results were suggestive of localization of 125I-RT3 in the Ewing's sarcoma cloned cell line as compared to other tissues , existence of a RT3 receptor in the Ewing's sarcoma line tested and the possibility for development of new selective chemotherapeutic agents based on this receptor. However, it is unclear at this time whether a radiolabeled RT3 will have any therapeutic applications, due to its decreased level of tumor binding as campared to radiolabeled monoclonal antibodies. On the other hand, the extremely rapid whole body clearance,potential for rapid penetration through tumors due to its decreased size may lead to consider alternative therapeutic strategies for radiolabeled RT3 such as the administration of multiple doses.
In order to confirm RT3 spcificity in Ewing's sarcoma, control study will be necessary by using non-specific hormone. And since RIs generally increased over time expanded studies using different sampling intervals and multidosing regimens (i.e., redosing at 4 hr) should improve understanding of the pharmacokinetics of RT3. Further investigations of the localization effects of RT3 on Ewing's sarcoma and other sarcomas are indicated. 
